Fig. 4
From: Novel drugs that target the metabolic reprogramming in renal cell cancer

A schematic overview of drugs that may interfere with glutamine-dependent lipogenesis
From: Novel drugs that target the metabolic reprogramming in renal cell cancer
A schematic overview of drugs that may interfere with glutamine-dependent lipogenesis